Investors Page

COAT: Clinically Validated Breakthrough

Read Peer‑Reviewed Study →

MemoryDriver
Now Live

Backed by Rigorous Science. Validated by $15M in NIH Funding

Since 2018, Evon Medics has secured nearly $15 million in highly competitive, non-dilutive funding from the National Institutes of Health (NIH). This robust institutional backing validates our foundational science and significantly de-risks our pathway to commercialization.

For Investments

Please Contact

Evaristus Nwulia, MD

Evaristus Nwulia, MD

Co-Founder & CSO